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In the food industry, there is a continuous search for ingredients that might provide advantageous pro-
perties to food products, either considering their nutritional value or bioactivity, as well as ﬂavouring and
technological aspects. Crude oils are good examples of this type of ingredient, especially if obtained from
nonconventional sources. Accordingly, the Opuntia macrorhiza Engelm. seed oil (OMSO) was chemically
characterized and evaluated for diﬀerent in vitro and in vivo bioactivities. OMSO presented physico-
chemical characteristics appropriate to be considered as an edible oil, namely low acidity value, stability
to oxidation (high peroxide value and low K232 and K270 values), and high contents of unsaturated fatty
acids (as shown by the iodine value) and saponiﬁable matter. Furthermore, this natural oil, owing to its
rich phytochemical proﬁle, showed relevant antioxidant activity (especially in lipid peroxidation inhibition
assays), α-glucosidase inhibitory activity, cytotoxicity against human tumour cell lines, antibacterial
(mainly against Gram positive species) and antifungal properties, as well as anti-inﬂammatory and
analgesic activities. Furthermore, OMSO did not show any sign of acute toxicity on animals, highlighting
its possible use in diﬀerent applications, considering that this natural product is not expected to induce
the adverse eﬀects typically associated with synthetic bioactive agents (e.g., ampicillin, amphotericin B,
or lysine acetylsalicilate).
Introduction
A good deal of scientific research has been recently focused on
natural compounds derived from plants. Some of the most
relevant targeted compounds include flavonoids, phenolic
acids, steroids, coumarins, terpenes and alkaloids, which
showed a wide range of biological activities, such as anti-
inflammatory, analgesic and antiproliferative properties,
besides having the additional advantage of inducing fewer
side eﬀects.1
Diﬀerent species belonging to the Opuntia genus
(Cactaceae), which are native to arid and semi-arid regions,
have been increasingly studied, using diﬀerent botanical
tissues, as high-potential sources of the previously indicated
compounds.2–6 Likewise, the biological activity of their pulps,
peels or cladodes was already validated.7–9 Related research
has also been directed towards Opuntia seeds, which have
already proved to be a source of natural antioxidants, mainly
flavonoids and tannins.3,5,10 Furthermore, the oil obtained
from Opuntia spp. seeds, which usually corresponds to 7–15%
of the whole seed weight,11 presents high contents of unsatu-
rated fatty acids (especially polyunsaturated), besides being
particularly rich in tocopherols (Chahdoura et al., 2015a;5
Simopoulos, 2002a12). In addition to phenolic compounds,
tocopherols might contribute to the antioxidant activity, as
these compounds are capable of influencing cellular responses
to various oxidative stresses by modulating signal-transduction
pathways,13 besides being associated with a reduced risk of
developing cardiovascular, inflammatory and autoimmune
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diseases. Other potential health benefits of Opuntia seeds,
namely their anti-inflammatory activity, are associated with
the presence of fatty acids of the n-3 and n-6 series, such as
linoleic (LA, C18:2n-6) and α-linolenic (ALA, C18:3n-3) acids,
the biosynthetic precursors of eicosanoids, which take part in
a wide range of metabolic processes (Simopoulos, 2002b14).
However, the complete characterization of the biological
activity of Opuntia species is still far from being available,
particularly in what concerns specific types of bioactivity, such
as α-glucosidase inhibition or the analgesic eﬀect.
Herein, an extensive set of laboratory assays was conducted
on the O. macrorhiza seed oil (OMSO), which was characterized
for diﬀerent physicochemical parameters (acidity, peroxide
value, extinction coeﬃcients, saponifiable matter and iodine
value), phytochemicals (carotenoids, chlorophylls, tocopherols
and volatiles) and several types of bioactivity (antioxidant
activity, cytotoxicity, α-glucosidase inhibition, antimicrobial
activity, analgesic eﬀect and anti-inflammatory properties).
The obtained results indicated that the otherwise discarded
O. macrorhiza seeds are a potential functional food, with
diﬀerent applications and additional economic benefits.
Experimental
Chemicals and reagents
Racemic tocol (50 mg mL−1) and tocopherols (α-, β-, γ-, and
δ-isoforms) were purchased from Matreya (Pleasant Gap, PA,
USA). 2,2-Diphenyl-1-picrylhydrazyl (DPPH), 2,2′-azino-bis
(3-ethylbenzothiazoline-6-sulphonic acid) diammonium salt
(ABTS), potassium ferricyanide [K3Fe(CN)6], ferric chloride
(FeCl3), trichloroacetic acid (TCA), β-carotene, linoleic acid,
hydrochloric acid (HCl), sodium hydroxide (NaOH), penicillin/
streptomycin solution (100 U mL−1 and 100 mg mL−1, respect-
ively), α-glucosidase (isolated from Aspergillus Niger), and
4-p-nitrophenyl-α-D-glucopyranoside (4-pNPG) were purchased
from Sigma-Aldrich. Mueller-Hinton agar, nutrient broth and
Brain Heart Infusion broth (BHI) were purchased from Biolife
(Monza, Italy). NaCl was obtained from CHEMI PHARMA,
Tunisia. Hexane, chloroform and methanol were purchased
from Merck (Darmstadt, Germany).
Samples
O. macrorhiza (Engelm.) fruits were manually harvested in
spring (2015) from the cliﬀ of Monastir (Tunisia) according to
the conventional standards of maturation (size and skin
colours). The seeds were separated from the juicy pulp,
washed abundantly with distilled water, dried at room temp-
erature for 24 h, weighed and then reduced to a fine homo-
genous powder (20 mesh). The plant material was identified
by Pr. Fethia Harzallah Skhiri (High Institute of Biotechnology
of Monastir, Tunisia). A voucher specimen (no. Oma 15-18)
has been deposited in the Herbarium of the Laboratory of
Bioressources: Biologie Integrative and Valorization, High
Institute of Biotechnology of Monastir.
Extraction
OMSO was extracted from a known weight (≈100 g) of pow-
dered seeds with hexane, using a Soxhlet apparatus (8 h).
OMSO was then filtered through a syringe filter of 0.2 µm and
stored at −20 °C in the dark, until analysis.
Physicochemical analyses
Acidity, peroxide value, extinction coeﬃcients (K232 and K270),
saponifiable matter and iodine value were determined accord-
ing to Oﬃcial Methods and Recommended Practices of the
American Oil Chemists’ Society (AOCS, 199815). The refractive
index was determined by using an Abbe refractometer (model
R-410A) with temperature adjustment.
Phytochemicals
Pigments. Carotenes and chlorophylls were determined in
cyclohexane extracts at 470 and 670 nm, respectively, using
specific extinction values (Minguez-Mosquera et al., 199116).
The results were expressed as mg of pheophytin “α” or lutein
per kg of OMSO.
Tocopherols. Tocopherol content was chromatographically
determined following a previously optimized procedure.5
Compounds were identified by chromatographic comparisons
with commercial standards and quantified considering the
fluorescence signal response of each standard, using the IS
(tocol) method and the calibration curves obtained from each
commercial standard. Results were expressed in mg per 100 g
of OMSO.
Volatile compound analyses. Volatile compounds were deter-
mined by headspace solid phase micro-extraction (HS-SPME)
coupled to gas chromatography/mass spectrometry (GC/MS) as
previously described.17
Antioxidant activity
Five antioxidant activity assays were performed for diﬀerent
concentrations of OMSO, previously diluted in methanol:
ABTS and DPPH radical scavenging activity, reducing power,
β-carotene bleaching inhibition and thiobarbituric acid reac-
tive substance (TBARS) formation inhibition.
In the ABTS assay, an aqueous solution of ABTS (7 mM) was
initially prepared. Then, the ABTS radical cation (ABTS•+) was
produced from the reaction (12–16 h in the dark, room temp-
erature) among the previous solution with 2.45 mM potassium
persulfate (final concentration).18 To study the radical scaven-
ging activity of OMSO, the ABTS•+ solution was diluted with
ethanol to an absorbance of ≈0.70 at 734 nm (equilibrated at
30 °C). The decrease (%) in absorbance at 734 nm achieved
after mixing the ethanolic solution of ABTS•+ (1 mL) and the
OMSO (10 μL) was calculated by comparison with Trolox refer-
ence data.18
Four other antioxidant activity assays were performed
as previously described.5 DPPH radical-scavenging activity
was evaluated by using an ELX800 microplate reader (Bio-
Tek Instruments, Inc.; Winooski, VT, USA) and calculated
as a percentage of DPPH discoloration using the formula:
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[(ADPPH − AS)/ADPPH] × 100, where AS is the absorbance of the
solution containing the sample at 515 nm, and ADPPH is the
absorbance of the DPPH solution.
Reducing power was evaluated by the capacity to convert
Fe3+ into Fe2+, measuring the absorbance at 690 nm in the
microplate reader mentioned above.
Inhibition of β-carotene bleaching was evaluated through
the β-carotene/linoleate assay; the neutralization of linoleate
free radicals avoids β-carotene bleaching, which is measured
by the formula: (β-carotene absorbance after 2 h of assay/
initial absorbance) × 100.
Inhibition of lipid peroxidation in porcine (Sus scrofa) brain
homogenates was evaluated by the decrease in TBARS for-
mation; the colour intensity of the malondialdehyde–
thiobarbituric acid (MDA-TBA) was measured at 532 nm; the
inhibition ratio (%) was calculated using the following
formula: [(A − B)/A] × 100%, where A and B are the absorbances
of the control and the sample solutions, respectively.
In all cases, the results were expressed as EC50 values
(sample concentration providing 50% of antioxidant activity or
0.5 of absorbance in the reducing power assay) in mg mL−1 of
extract. Trolox was used as a positive control.
Cytotoxicity
Human tumour cell lines. Four human tumour cell lines
were used: MCF-7 (breast carcinoma), NCI-H460 (non-small
cell lung cancer), HeLa (cervical carcinoma) and HepG2
(hepatocellular carcinoma). Cells were maintained as adherent
cultures in RPMI-1640 medium containing 10% heat-inacti-
vated FBS and 2 mM glutamine, at 37 °C, in a humidified air
incubator containing 5% CO2. Each cell line was plated at an
appropriate density (7.5 × 103 cells per well for MCF-7 and
NCI-H460 or 1.0 × 104 cells per well for HeLa and HepG2) in
96-well plates. The sulforhodamine B assay was performed as
previously described.19 Results were expressed as GI50 values
(sample concentration that inhibited 50% of the net cell
growth) in mg mL−1.
Non-tumour liver cell primary culture. A cell culture (PLP2)
was prepared from a freshly harvested porcine liver obtained
from a local slaughter house and cultured as previously
described.19 Before confluence was reached, cells were sub-
cultured and plated in 96-well plates (≈1.0 × 104 cells per well),
using DMEM with 10% FBS, 100 U mL−1 penicillin and 100
μg mL−1 streptomycin. Results were expressed as GI50 values,
in mg mL−1. Ellipticine was used as a positive control.
α-Glucosidase inhibition assay
Enzyme activity was measured following a previous pro-
cedure,20 with some modifications. The α-glucosidase reaction
mixture, containing 2.5 mM 4-p-nitrophenyl-α-D-glucopyrano-
side (4-pNPG), 250 µL of OMSO at diﬀerent concentrations in
DMSO and 0.3 U mL−1 of α-glucosidase in phosphate buﬀer
pH 6.9, was incubated in a water bath (37 °C, 15 min).
Negative control tubes contained only DMSO, enzyme and sub-
strate, while in positive controls Acarbose replaced OMSO. The
absorbance (405 nm) of the resulting p-nitrophenol (pNP) was
considered directly proportional to the enzyme activity.
Percentage inhibition (I%) of OMSO and Acarbose was calcu-
lated using the following formula:
I% ¼ ðAcontrol  AsampleÞ=Acontrol  100
where Acontrol and Asample are the absorbance values of the
negative control and sample, respectively. Results were pre-
sented as IC50 (mg mL
−1) values (concentration of OMSO
required to inhibit 50% of intestinal α-glucosidase).
Antimicrobial activity
Microorganisms. The tested microorganisms included
Gram-positive: Staphylococcus aureus ATCC 25923, Listeria
monocytogenes ATCC 19115, Bacillus cereus ATCC 11778 and
Enterococcus faecalis ATCC 29212 and Gram negative: Vibrio
parahaemolyticus ATCC 17802, Escherichia coli ATCC 35218,
Pseudomonas aeruginosa ATCC 27853 and Salmonella typhimur-
ium ATCC 1408 bacteria and four Candida strains (C. albicans
ATCC 2091, C. parapsilosis ATCC 22019, C. glabrata 06-085 and
C. krusei ATCC 6258).
Disc-diﬀusion assay. For antimicrobial activity experiments,
10 µL of the microorganism working stock solutions were
enriched on a tube containing 9 mL of Mueller-Hinton broth
(for bacteria) and Sabouraud Chloramphenicol broth
(for Candida) and further incubated at 37 °C for 24 h.21 The
optical density was adjusted (0.1 at OD600 for bacteria and
0.4 at OD540 for Candida strains). The inocula of the respective
bacteria and fungus were streaked onto agar plates using a
sterile cotton swab as recommended by the CA-SFM EUCAST
2017. Sterile filter discs (diameter 6 mm, Biolife Italy) were
impregnated with 10 µL of OMSO and placed on the appropri-
ate media. Ampicillin (10 mg mL−1; 10 µL per disc) and
Amphotericin B (10 mg mL−1; 10 µL per disc) were used as
positive reference standards. After 24 h of incubation at 37 °C,
the diameter of the growth inhibition zone was measured with
a flat millimetric rule.
Micro-well determination of MICs and MBCs/MFCs. The
minimal inhibition concentration (MIC) and the minimal bac-
tericidal/fungicidal concentration (MBC/MFC) values were
determined for all the bacterial/fungal strains.22 The bacterial/
fungal inocula, prepared from 12 h broth cultures and suspen-
sions, were spectrophotometrically adjusted to 107 UFC mL−1.
OMSO was first dissolved in 10% dimethylsulfoxide (DMSO) to
the highest concentration (50 mg mL−1), and then serial
twofold dilutions were made in a concentration range from 25
to 0.048 mg mL−1 in 5 mL sterile glass tubes containing nutri-
ent broth. 96-well plates were prepared by dispensing into
each well 95 µL of nutrient broth. A 100 µL aliquot from the
stock solutions of the tested OMSO was added into the wells,
followed by 5 µL of each microbial suspension. The first well
containing 195 µL of nutrient broth (Mueller Hinton broth or
Sabouraud Chloramphenicol broth) without OMSO and 5 µL
of the inoculum was used as a negative control. The final
volume in each well was 200 µL. The plates were incubated at
37 °C for 24 h. The MIC was defined as the lowest concen-
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tration of the compounds to inhibit the growth of the micro-
organisms. The MBC/MFC values were interpreted as the
highest dilution (lowest concentration) of the sample, which
showed a clear fluid with no development of turbidity and
without visible growth. All the tests were performed in triplicate.
Animal tests
Animals were obtained from the Pasteur Institute (Tunis,
Tunisia). Male adult Wistar rats weighing 160–180 g were used
for the anti-inflammatory evaluation of OMSO. Also, Swiss
albinos mice (weighing 18–25 g) were used for the analgesic
investigation and for acute toxicity testing on both sex. They
were housed in polypropylene cages and were left for 2 days
for acclimatization to the animal room, maintained under
controlled conditions (12 h light–dark cycles at 22 ± 2 °C) on a
standard pellet diet and water ad libitum. Before the day of
assay, the Wistar rats and Swiss albinos mice were fasted over-
night with free access to water. Animals were handled according
to the guidelines of the Tunisian Society for the Care and Use of
Laboratory Animals (ATSAL), and the protocol for the rat studies
was approved by Institutional Animal Ethics Committee for
Animal Care and Use, Bizerte University, Carthage.
Acute toxicity. Mice were divided into groups of six animals
each. Five groups were used to study toxicity using a single
intraperitoneal dose. Each group received, respectively, a
single dose of 0.5, 1, 2 and 3 g per kg body weight of OMSO or
distilled water (10 mL kg−1). After treatment, the mortality rate
within a 48 h period and autonomic toxic eﬀects were
determined.
Analgesic activity. Analgesic activity was assessed by the
acetic acid abdominal constriction test (writhing test), a chemi-
cal visceral pain model.23 Swiss albinos mice were selected 1 day
prior to each test and were divided into groups of six mice each.
Negative and positive controls were dermally pre-treated with
10 mL kg−1 of saline solution or 200 mg kg−1 of the reference
drug lysine acetylsalicylate (ASL), respectively. The remaining
groups were injected intraperitoneally with 10 mL kg−1 of 1%
acetic acid solution 30 min after the administration of diﬀerent
doses of 0.5, 1.0 and 2.5 g kg−1 of OMSO. Afterwards, the
number of writhes was counted during 30 min. Antinociceptive
activity was expressed as the inhibition percentage of the usual
number of writhes observed in control animals. The percen-
tages of inhibition were calculated according to the formula:
% Inhibition ¼ððnumber of writhesÞcontrol
 ðnumber of writhesÞtreated groupÞ
 100=ðnumber of writhesÞcontrol
Anti-inflammatory activity. Anti-inflammatory activity was
assessed based on the inhibition of paw oedema induced by
the injection of carrageenan (an oedematogenic agent) into
the sub-plantar region of the right hind paw.24 Male Wistar
rats were divided into diﬀerent groups of 6 animals. Negative
and positive controls received 2.5 mL kg−1 of saline solution or
300 mg kg−1 of ASL, respectively. Test groups received diﬀerent
concentrations (0.5, 1.0 and 2.5 g kg−1) of OMSO. Thirteen
minutes after intraperitoneal administration of diﬀerent sub-
stances, 0.05 mL of a carrageen suspension (1%) was injected to
all animals in the right hind paw. The paw volume, up to tibio-
tarsal articulation, was measured using a plethysmometer at 0 h
(V0: before oedematogenic agent injection) and 1, 2, 3, 4, 5 and
24 h intervals later (VT). The diﬀerence between VT (1, 2, 3, 4, 5
and 24 h) and V0 was taken as the oedema value. The percen-
tages of inhibition were calculated according to the formula:
% Inhibition ¼ððVT  V0Þcontrol  ðVT  V0Þtreated groupÞ
 100=ðVT  V0Þcontrol
Statistical analysis
All the tests were carried out for three sample replications and
the results were averaged. The means ± standard deviation
(SD) of data was calculated from independent experiments.
The exact sample size (n) for each experimental group is
reported in the manuscript and in table captions. Data ana-
lysis was carried out using one-way ANOVA analyses followed
by the Student–Newman–Keuls post hoc test. Statistical ana-
lyses were performed using GraphPad Prism and InStat soft-
wares (GraphPad Software, La Jolla, USA). All statistical tests
were two-tailed and a p value ≤0.05 was considered significant.
Results and discussion
Physicochemical parameters
The physicochemical parameters relevant to assess the oil
quality are reported in Table 1. OMSO is liquid at room temp-
erature and it has a yellow–brown colour and mild, yet charac-
teristic, flavour and odour. The detected acidity was very low
(1.15%), and even lower than the one (1.41–1.82%) reported
for Opuntia ficus indica seeds’ oil,25,26 fulfilling the acceptabil-
ity criterion that defines a maximum acidity of 3%.27 The
iodine value is high (110 g of I2 per 100 g), reflecting the high
content in unsaturated fatty acids.5 Likewise, the peroxide
index was 2.8 meq per O2 per kg of OMSO, indicating a good
stability to oxidation and suggesting, together with the iodine
value, good edible quality. The peroxide index values are close
to those reported for the seed oil of O. ficus indica.25,26,28 The
resistance to oxidation is also reflected by the low extinction
coeﬃcients (0.98 and 0.015 at 232 and 270 nm, respectively).
Table 1 Physicochemical parameters evaluated in OMSO
Parameter Mean value ± SD (n = 3)
Free acidity (%) 1.15 ± 0.05
Saponification value
(mg of KOH per g of oil)
179 ± 1
Iodine value (g I2 per 100 g) 110 ± 1
Peroxide value (meq O2 per kg of oil) 2.8 ± 0.2
Refractive index (20°) 1.48 ± 0.01
Extinction coeﬃcients
K232 0.98 ± 0.05
K270 0.015 ± 0.003
Physical state at room temperature Liquid
Oil colour Yellow–brown
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In fact, K232 is an indicator of the formation of hydroperoxide
and conjugated dienes, while K270 nm is associated with the
secondary phase of oxidation, reflecting the presence of the
final products (such as trienes or unsaturated carbonyl com-
pounds), which contribute to the characteristic flavour of oxi-
dized oils.29 Lastly, the saponification value was 179 mg of
KOH per g of OMSO, also in good agreement with the ones
(177–181 mg of KOH per g) reported for O. ficus indica oil.25,26
Nevertheless, despite the pointed out similarities with the
seed oil from O. ficus indica, it should be highlighted that the
seeds of O. macrorhiza provide a higher oil quantity (around
10 g per 100 g dry weight) than that achievable with O. ficus
indica (≈5 g per 100 g dry weight).26 In either case, the oils
obtained from Opuntia seeds are expected to be good sources
of mineral elements as well, particularly phosphorous,
calcium and potassium.30
Phytochemicals
Among pigment compounds (Table 2), β-carotene was the
major one (41.8 mg kg−1), opening the way for diﬀerent uses,
especially in the cosmetic industry. Chlorophylls were present
in lower amounts (3.0 mg kg−1), in agreement with typical
values reported for the Opuntia genus.28 Chlorophylls and
carotenoids are important to determine the oil quality, mostly
due to their contribution to the oil colour, which is a relevant
parameter when assessing the overall quality.31 Furthermore,
carotenoids are well-known quenchers of singlet oxygen, being
able to protect oils from photo-oxidation.32
Regarding tocopherol contents (Table 2), four isoforms
(α, β, γ and δ-tocopherol) were identified, with γ-tocopherol as
the major component. This particular isoform was also reported
as the main constituent (9.8 mg per 100 g of oil) in the seed
oil of O. ficus indica.33 Considering their prevention activity on
the peroxidation of polyunsaturated fatty acids, tocopherols
certainly contribute to OMSO stability towards oxidation,34
improving its quality by preserving it from rancidity during
storage and prolonging its shelf-life.35
Additionally, the headspace of OMSO was characterized by
13 spontaneously emitted volatile compounds (Table 2). The
chemical analysis revealed high contents of ethyl valerate
(58.1%), known for its floral sensory notes, and camphor
(19.6%), an oxygenated monoterpene with a typical aromatic
odour.36 All the remaining volatiles were detected in percen-
tages below 5%. Besides their contribution to the aroma
profile of OMSO, these compounds might also influence its
physical and biological properties.37
Antioxidant activity
OMSO showed to be particularly active in preventing lipid
peroxidation, as indicated by the results obtained in the
inhibition of TBARS formation (EC50 = 0.90 mg mL
−1) and
β-carotene bleaching inhibition (EC50 = 10 mg mL−1).
The EC50 values for all assays (Table 3) are similar to those
reported for the polar extracts of seeds, as also to those reported
for other tissues (cladodes and flowers) of O. macrorhiza.5,38
Besides its lipid peroxidation inhibition, OMSO also has a good
radical scavenging activity (DPPH EC50 = 1.99 mg mL
−1; ABTS•+
EC50 = 3.62 mg mL
−1) and reducing power (EC50 = 1.24
mg mL−1). The detected antioxidant activity is in agreement
with the low values of K232 and K270, and should be associated
(as previously indicated) with the contents in tocopherols and
carotenoids (see section Phytochemicals). In fact, it was reported
that tocopherols (especially γ-tocopherol) could enhance the
activity of superoxide dismutase, thereby contributing to
diﬀerent antioxidant eﬀects.39
Cytotoxic activity
The cytotoxic eﬀect of OMSO on diﬀerent cell lines (HeLa,
HepG2, MCF 7 and HCT15), which had not been previously
reported, is shown in Table 4. With the exception of MCF7
cells, OMSO was active against all the tested tumour cell lines,
with GI50 values ranging from 105 μg mL−1, in the case of
Table 2 Phytochemicals quantiﬁed in OMSO
Compound Mean value ± SD (n = 3)
Tocopherols (mg per 100 g of OMSO)
α-Tocopherol 0.34 ± 0.01
β-Tocopherol 0.36 ± 0.01
γ-Tocopherol 9.8 ± 0.1
δ-Tocopherol 0.20 ± 0.01
Total tocopherols 10.7 ± 0.1
Pigments (mg kg−1 of OMSO)
Chlorophylls 3.0 ± 0.1
β-Carotene 41.8 ± 0.1
Volatilesa LRIb (%)c
4-Hydroxy-4-methyl-2-pentanone 847 1.32 ± 0.01
Ethyl isovalerate 854 1.70 ± 0.02
n-Nonane 900 4.12 ± 0.01
Ethyl valerate 902 58.1 ± 0.1
α-Pinene 941 1.04 ± 0.01
Camphene 955 1.22 ± 0.01
n-Decane 1000 1.13 ± 0.03
β-Phellandrene 1033 2.32 ± 0.02
1,8-Cineole 1035 3.04 ± 0.04
(E)-2-Octenal 1063 1.24 ± 0.01
n-Undecane 1100 2.04 ± 0.04
Nonanal 1102 1.31 ± 0.01
Camphor 1145 19.6 ± 0.1
a Identification was performed by the calculation of L.R.I and by MS
data. b LRI: linear retention indices (HP-5 column). c%: percentage cal-
culated by GC-FID on non-polar capillary column HP-5.
Table 3 Antioxidant activity of OMSO (values are presented as mean
values ± SD)
Antioxidant activity EC50
a (mg mL−1)
DPPH scavenging activity 1.99 ± 0.01
ABTS 3.62 ± 0.02
Reducing power 1.24 ± 0.04
β-Carotene bleaching inhibition 1.10 ± 0.01
TBARS inhibition 0.90 ± 0.02
a EC50: OMSO concentration corresponding to 50% of antioxidant
activity or 0.5 of absorbance in reducing power assay.
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HCT15 (colon carcinoma), to 358 μg mL−1, for HepG2
(hepatocellular carcinoma). Therefore, HCT15 was the most
susceptible cell line, while MCF7 resulted to be the most resist-
ant one. Interestingly, OMSO showed no toxicity (up to 400
μg mL−1) against the non-tumour cell line PLP2.
In vitro α-glucosidase inhibition assay
The maintenance of blood glucose levels is a very important
subject, continuously required for eﬀective approaches, such
as the inhibition of α-glucosidase, which leads to a decrease in
the rate of glucose absorption, lowering its postprandial blood
levels.40 Accordingly, the capacity of OMSO to inhibit
α-glucosidase was also assessed, having been obtained an EC50
value of 0.34 mg mL−1, which is similar to that of Acarbose
(EC50 = 0.26 mg ml
−1), used herein as the positive control.
Therefore, OMSO might be an interesting alternative, as it is
not expected to induce side eﬀects (such as abdominal pain,
flatulence and diarrhoea) that are usually associated with
other blood glucose controlling agents.41
The eﬀectiveness of OMSO in this particular type of bioacti-
vity might be related to its high levels of tocopherols, since it
has been reported that the administration of γ-tocopherol to dia-
betes mellitus patients exerts a blood glucose lowering eﬀect.42
Antimicrobial activity
Data on the antimicrobial activity of OMSO, reported herein
for the first time, are given as inhibition zone (IZ) diameters,
MICs and MBCs/MFCs (Table 5). The antibacterial activity was
substantially higher among Gram positive (IZ from 7 to
11 mm) and yeast (IZ from 10.3 to 12.3 mm) strains, with
Listeria monocytogenes (IZ = 11 mm; MIC = 0.390 mg mL−1;
MBC = 1.56 mg mL−1) and Candida albicans (IZ = 12.3 mm;
MIC = 0.781 mg mL−1; MFC = 1.56 mg mL−1) as the most sen-
sitive species. The presence of camphor (19.6%), 1,8-cineole
(3.04%) and α-pinene (1.04%) might explain the antimicrobial
properties against Gram positive bacteria and yeast, owing to
their capacity to destroy the cellular integrity of bacteria and to
inhibit the respiratory activity in yeast mitochondria.43,44 On
the other hand, OMSO was less eﬀective against Gram negative
bacteria (IZ around 6.0 mm), with Pseudomonas aeruginosa as
the most resistant species (IZ = 6.0 mm; MIC = 12.5 mg mL−1;
Table 4 Cytotoxic activity of OMSO (values are presented as mean
values ± SD)
Cell lines GI50
a (μg mL−1)
Human tumour cell lines
MCF7 (breast carcinoma) >400
HCT15 (colon carcinoma) 215 ± 5
HeLa (cervical carcinoma) 105 ± 4
HepG2 (hepatocellular carcinoma) 358 ± 11
Non-tumour cells
PLP2 >400
aGI50 values correspond to the OMSO concentration achieving 50% of
growth inhibition.
Table 5 Antibacterial and antifungal activity (MIC, MBC and MFC in mg mL−1) of OMSO
Microorganisms
OMSO Drug
IZa MICb MBCc IZa MICb MBCc/MFCd
Bacterial strains Ampicillin
Staphylococcus aureus ATCC 25923 10.3 ± 0.5 0.781 3.12 32.5 ± 0.5 0.078 0.625
Listeria monocytogenes ATCC 19115 11 ± 1 0.390 1.56 12.3 ± 0.5 0.023 0.093
Bacilus aureus ATCC 11778 7.0 ± 0.5 1.56 12.5 26 ± 1 0.078 0.625
Enterococcus faecalis ATCC 29212 8 ± 1 0.781 6.25 13.7 ± 0.5 0.023 0.093
Vibrio parahaemolyticus ATCC 17802 6.0 ± 0.5 3.12 >25.0 13.3 ± 0.5 0.011 3.00
Escherichia coli ATCC 35218 6.0 ± 0.5 6.25 >25.0 11.7 ± 0.5 0.023 3.00
Pseudomonas aeruginosa ATCC 27853 6.0 ± 0.5 12.50 >25.0 22.7 ± 0.5 0.011 12.0
Salmonella typhimurium ATCC 1408 6.0 ± 0.5 6.25 >25.0 18 ± 1 0.023 0.093
Yeast strains IZa MICb MFCd Amphotericin B
Candida albicans ATCC 2019 12.3 ± 0.5 0.781 1.56 14.7 ± 0.5 0.024 0.781
Candida krusei ATCC 6258 10.3 ± 0.5 3.12 12.5 12.0 ± 0.5 0.097 0.195
Candida glabrata ATCC 15126 10.3 ± 0.5 1.56 6.25 6.0 ± 0.5 0.39 6.25
Candida parapsilosis ATCC 22019 11 ± 1 0.781 3.12 10.3 ± 0.5 0.20 0.39
a IZ: inhibition zone (mm) around discs impregnated with OMSO (10 mg per disk), Ampicillin (10 mg mL−1) or Amphotericin B (10 mg mL−1)
expressed as mean ± SD (n = 3). bMIC: minimal inhibitory concentration (mg mL−1). cMBC: minimal bactericidal concentration (mg mL−1).
dMFC: minimal fungicidal concentration (mg mL−1).
Table 6 Eﬀects of OMSO on acetic acid-induced writhing in mice
Group
Concentration
(g kg−1)
Number of
writhesa
Writhing
inhibition (%)
Control — 100 ± 4a —
0.5 37 ± 5b 63
OMSO 1 25 ± 4b 75
2.5 16 ± 2c 84
Reference drug (ASL)b 0.2 32 ± 5b 68
a Values are expressed as mean ± SD (n = 6). Diﬀerent letters in this
column indicate statistically significant diﬀerences (p < 0.05) among
values according to the Student–Newman–Keuls post hoc test. b ASL:
lysine acetylsalicylate.
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MBC > 25.0 mg mL−1). When compared to commercial
drugs, the antibacterial activity of OMSO was lower than
ampicillin (despite the similarity of the IZ in the case of
L. monocytogenes). However, the antifungal activity was very
similar (specifically considering IZ) to the one achieved with
amphotericin B, which might be an indicator of the potential
use of OMSO in related applications.
Animal tests
Acute toxicity. Swiss albinos mice were observed for 48 h and
morbidity and/or mortality were recorded. The tested OMSO
concentrations did not exhibit any mortality or toxicity
symptoms in all groups receiving intraperitoneally doses up to a
maximum of 5 g kg−1 body weight, indicating its potential safe
use below that concentration. The non-toxic nature of OMSO is
comparable to that observed for O. ficus indica seed oil.45
Analgesic activity. The analgesic eﬀect of OMSO, assessed as
the percent reduction of the number of writhes induced with
acetic acid, was shown to be proportional to the administered
concentration (Table 6). In fact, the highest percent reduction
(84%) was achieved with the highest assayed concentration
(2.5 g kg−1), which is still below the maximum value showing
non-toxic eﬀects (see the previous section). Still, all assayed
OMSO concentrations induced a significantly lower number of
writhes than the corresponding control (p < 0.05). The excel-
lent analgesic activity of OMSO, which might be related to its
composition in unsaponifiable compounds,46 is also validated
by its similarity to the one (68% at 0.2 g kg−1) achieved with
the commercial standard (ASL). Furthermore, it should be
highlighted that the applied methodology allows investigating
both central and peripheral analgesic activities.46
Anti-inflammatory activity. As reported in Table 7, OMSO
decreased the carrageenan induced oedema rates in the sub-
plantar region of the hind paw in a dose-related manner (in all
periods of time), reaching the maximum inhibition percen-
tages at 2.5 g kg−1 (81%). The level of anti-inflammatory
activity was remarkable, being comparable to the one obtained
with the positive control (lysine acetylsalicylate), despite the
diﬀerences in the assayed concentrations. The maximum anti-
inflammatory eﬀect was achieved after 4 hours for all the
doses, independent of the administered dose. In general, there
was a gradual increase in oedema paw volume in the control
group up to 5 h after carrageenan injection, further showing a
marked decrease from 5 to 24 h. The observed anti-inflamma-
tory activity might be associated with an inhibitory eﬀect over
the release of pro-inflammatory mediators of acute inflam-
mation, such as histamine and prostaglandins. In fact, some
of the compounds (e.g., γ-tocopherol) present in the unsapo-
nifable fraction of OMSO may exert anti-inflammatory eﬀects
by inhibiting the synthesis, release and/or the action of inflam-
matory mediators like histamine, serotonin and diﬀerent
prostaglandins.47
Conclusions
In general, OMSO showed good characteristics to be con-
sidered as a new edible oil, as exemplified by its low acidity
value (1.15%), stability to oxidation (considering its high per-
oxide value and low K232 and K270 values), high content of
unsaturated fatty acids (as indicated by the iodine value) and
the quantity of saponifiable matter.
OMSO showed high antioxidant activity (especially regard-
ing lipid peroxidation inhibition), which might be related to
its high contents of β-carotene and γ-tocopherol. The high
levels of tocopherol could also be related to its α-glucosidase
inhibitory activity, which should be considered as a promising
result, since this natural product is not expected to induce the
adverse eﬀects typically caused by other blood glucose control-
ling agents.
In addition, this oil exerted a cytotoxic eﬀect on the tested
human tumour cell lines (except MCF7), among which HCT15
(colon carcinoma) was the most susceptible. Nevertheless, it
did not show toxicity against the non-tumour cell line PLP2
(up to 400 μg mL−1).
Concerning the antimicrobial activity, which could be related
to its volatiles, OMSO was more eﬀective against Gram positive
and yeast strains, showing very positive results, even when com-
pared with commercial drugs (ampicillin and amphotericin B).
The detected bioactivity became particularly interesting
after verifying that OMSO did not exert acute toxicity in animal
testing. Furthermore, this natural oil presented high analgesic
Table 7 Eﬀects of OMSO on the rat paw carrageenan induced oedema
Group Dose (g kg−1)
Mean swelling thickness (10−2) ± SDa (% of inhibition)b
1 h 2 h 3 h 4 h 5 h 24 h
Control — 21 ± 1a 31 ± 2a 50 ± 2a 53 ± 3a 55 ± 2a 30 ± 1a
0.5 17 ± 1a (19%) 21 ± 1b (32%) 21 ± 1b (58%) 21 ± 1b (60%) 24 ± 1b (56%) 12 ± 1c (59%)
OMSO 1 15 ± 1b (28%) 15 ± 1c (51%) 18 ± 1c (64%) 15 ± 1c (71%) 19 ± 1c (66%) 9 ± 1d (70%)
2.5 10 ± 3b (52%) 12 ± 1c (61%) 15 ± 1c (70%) 10 ± 1d (81%) 12 ± 1d (78%) 6 ± 1e (80%)
ASLc 0.3 10 ± 1b (5210%) 13 ± 1c (58%) 20 ± 1b (60%) 18 ± 1b (66%) 20 ± 1c (64%) 16 ± 1b (47%)
a Values are expressed as mean ± SD (n = 6 animals per dose per time point). Diﬀerent letters in each column indicate statistically significant
diﬀerences (p < 0.05) among values according to the Student–Newman–Keuls post hoc test. b Percent swelling = ((Vf − Vi)/Vi) × 100, where Vi is the
initial paw volume and Vf is the paw volume after the carrageenan injection.
c ASL: lysine acetylsalicylate.
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and anti-inflammatory properties, especially when tested at
2.5 mg per kg bw, a concentration below the one (5 mg per kg
bw) validated as having no toxic eﬀects.
Overall, the present findings suggest possible applications
(e.g., nutraceutical, pharmacological or cosmetic) of OMSO, an
otherwise undervalued by-product, which might yield impor-
tant economic benefits.
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